• Gene One Life Science postponed receipt of convertible bond sale proceeds from October 29, 2026, to April 29, 2027.
• The KRW 1.5 billion sale’s buyer changed to Revolt Investment Partnership from Seonkwang System.
• Proceeds will fund operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261029000655), on October 29, 2026, and is solely responsible for the information contained therein.